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ABSTRACT
Purpose: We investigated the international differences in the reporting of lower urinary tract 
symptoms and related bother in patients with symptoms suggestive of bladder outlet obstruction.
Materials and Methods: Multiple logistic regression analysis was used to evaluate interna­
tional differences in the reporting of lower urinary tract symptoms and related bother in 1,271 
patients from 12 countries who participated in the International Continence Society “benign 
prostatic hyperplasia” study.
Results: Country of origin was significantly associated with the prevalence of a large number 
of lower urinary tract symptoms (10 of 20), even after adjusting for potentially confounding 
variables, including physical and socio-demographic factors. Country of origin was also signifi­
cantly associated with the reporting of bother but for a much smaller number of symptoms (2).
Conclusions: In different countries lower urinary tract symptoms may be reported to different 
extents. Therefore, the results of studies in particular countries may not be generally applicable 
to other countries. It is likely that symptom scores will conceal this variation, necessitating consid­
eration of individual symptoms (as in the International Continence Society “benign prostatic hyper­
plasia” study) or the development of country specific scoring systems. An alternative would be to focus 
on bother, which appeared to be much less sensitive to international differences.
K ey W ords: prostatic hypertrophy, urinary incontinence, urination disorders, urinary  tract
Lower urinary tract symptoms, traditionally labeled pros­
tatism, are accepted by most cultures as an inevitable con­
sequence of aging .1*2 The term  prostatism implies cause and 
remedy, whereas in reality the condition results not only 
from infravesical bladder outlet obstruction caused by the 
enlarged prostate gland bu t also from motor or sensory ab­
normalities of detrusor and urethral function ,3 or even from 
habit and changes in life-style th a t commonly occur as men 
grow older. Race, food, country of origin and other environ­
mental factors are reported to be related to the prevalence of 
lower urinary tract symptoms but epidemiological studies 
are subject to many pitfalls and the data must be interpreted 
with great caution, particularly because a widely accepted 
definition of clinical benign prostatic hyperplasia (BPH) has 
not been established .2»4*5 The reported international differ­
ences in the prevalence of lower urinary tract symptoms may 
reflect true differences in the prevalence of BPH but they 
may also be related to cultural differences in the perception 
of or willingness to report symptoms. The prevalence of 
symptoms in the community is greater than the number of 
men who seek medical or surgical help, indicating that men 
do not always perceive th a t the lower urinary tract symptoms 
cause problems.1*6 The perception of lower urinary trac t 
symptoms seems to be a personal m atter th a t could be dis­
similar among men in different age groups, and various en­
vironmental and socio-demographic circumstances. Recently, 
Abrams suggested th a t the terminology in this area should
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be redefined .7 BPH is a  histological diagnosis th a t was shown 
by Berry et al to occur in  8 8 % of m en older th an  80 years .8 
Although prevalent, BPH  m ay not lead to the clinical diag­
nosis of benign pro sta tic  en largem ent or to the uro dynamic 
diagnosis of benign prosta tic  obstruction. Similarly, even 
though benign prostatic obstruction exists, th e  pa tien t may 
not be bothered by lower u rin a ry  trac t symptoms.7
M any questionnaires have been developed for use by pa­
tien ts with lower u rin a ry  tra c t sym ptom s .9-13 Four question­
naires have been validated  in  pa tien ts  w ith the clinical diag­
nosis of B PH 9*10,13,14 bu t to our knowledge none has 
investigated the relationships w ith  the  uro dynamic diagnosis 
of bladder outlet obstruction.
In  1991 the  In ternational Continence Society began an 
in ternational m ulticenter study in patien ts  with lower u r i­
nary  tract symptoms suggestive of b ladder outlet obstruction 
to validate a new questionnaire incorporating all u rinary  
symptoms, related problem s and quality  of life issues th a t 
could indicate obstruction, detrusor instability , detrusor u n ­
deractivity and other u rin a ry  conditions. The aims of the 
study were to investigate th e  relationship  between the re ­
sults of uro dynamic stud ies and a wide range of urinary  
symptoms, develop and  validate  an  In ternational Continence 
Society “BPH” symptom score for use in  research and clinical 
practice, and compare p re trea tm en t and posttreatm ent 
symptoms with th e  resu lts  of advanced uro dynamic 
pressure-flow study evaluation, used as the  gold standard  for 
quantification of the  degree of obstruction in elderly m en ,15 to 
be able to define th e  characteristics of patien ts who will 
benefit from current therap ies.
We investigated in ternational differences in the reporting of
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lower urinary  tract symptoms and related bother in patients 
with symptoms suggestive of bladder outlet obstruction.
M A TER IA L AND M E T H O D S
In the  In ternational Continence Society “BPH” study 1,271 
patients older th a n  45 years w ith  lower u rinary  tract symp­
toms suggestive of b ladder outlet obstruction who were well 
enough to undergo prostatic  surgery, if appropriate, were 
recruited from general urology practices in  12 countries (ta­
ble 1). P a tien ts  were excluded from the study  if they had  an 
abnormal m idstream  urine specimen or significant other uro­
logical disease, such as p rosta te  cancer, neurological disease 
or previous prostatic  surgery, or if they  were taking medica­
tion active on th e  lower u rin a ry  tract.
All patien ts were evaluated  a t baseline by medical history, 
including questions concerning th e  home location (city or 
town center, suburbs, village or rural), m arita l sta tus (mar­
ried, living as m arried  or single), work situation (employed, 
retired  or unemployed), an d  the  preoperative anesthetic risk 
as indicated by the  physician (minimal or moderate to se­
vere). Symptoms were evaluated by the  In ternational Conti­
nence Society “BPH” study questionnaire, which allows men 
to report the frequency of symptoms associated w ith  the 
filling, voiding and post-voiding phases, and  also to assess 
the degree of bother th a t  they  cause .14 The questionnaire also 
contains specific questions th a t  focus on issues concerned 
with sexual function and th e  effects of symptoms on daily life. 
The In ternational Continence Society m ale questionnaire 
was developed in English and th en  professionally translated 
into 10 other languages. E ach transla tion  was then back 
transla ted  and evaluated by a lay advisor or senior urologist 
from each country who was nom inated as a national coordi­
nator for the  In te rna tiona l Continence Society “BPH” 
study .14 Donovan e t al dem onstrated  th a t w ith the In te rna­
tional Continence Society m ale questionnaire it was possible 
to differentiate betw een m en in  clinical and community pop­
ulations, and to detect the  expected positive age gradient for 
most symptoms in  the  com m unity group .14 There was rea­
sonable agreem ent betw een relevant parts  of the question­
naire, and the frequency and  volume charts. In ternal consis­
tency was high, and overall the  questionnaire demonstrated 
good tes t-re tes t re liab ility .14 Furtherm ore, patients under­
w ent a physical exam ination, including digital rectal exami­
nation w ith  estim ation of the  prostatic volume and an  op­
tional u ltrasonographic exam ination  of th e  prostate ,3 free 
uroflowmetry studies w ith  subsequent m easurem ent of re­
sidual u rine  (the h ighest m axim um  flow ra te  was used for the 
analysis) and  urodynam ic pressure-flow studies.
S tatistics were used to describe the pa tien t population, and 
to provide an  overview of th e  reported prevalence of each 
symptom and re la ted  problem  for each country. Differences 
across the countries in  m edians for quantitative variables 
and differences in distributions for categorical variables were
tested with the Kruskal-Wallis 1-way analysis of variance 
and chi-square tests, respectively. The impact of country of 
origin was studied on the reported prevalence of symptoms 
and related bother by using multiple logistic regression anal­
yses.
Initially, international differences for each symptom and 
related bother were tested by entering country alone (repre­
sented by 10 dummy variables) into a logistic regression 
model. Step 2 was to determine if adjusting for confounding 
variables changed these results. The possible confounding 
variables included location of the home, m arital status, pa­
tient work situation, preoperative anesthetic risk as indi­
cated by the physician (all categorical), age, maximum flow 
rate and prostatic volume (quantitative). The logistic regres­
sion analysis was done for 977 patients for whom complete 
data were available. Odds ratios and 95% confidence in­
tervals were calculated for each country using the United 
Kingdom as the reference country. Given the num ber of 
significance tests performed in each analysis, statistical sig­
nificance should be interpreted with caution. Applying the 
Bonferroni correction for multiple testing would imply a cut­
off point of approximately 0.0025 for each individual p value 
to retain  an overall 5% significance level. Since the symptoms 
were strongly associated with each other, such a correction 
would be conservative. Therefore, for the present analyses a 
cutoff point of 1% was used, with a significance of 1 to 5% 
being regarded as marginal.
RESULTS
Patients with a wide range of objective variables, such as 
maximum flow rate, voided volume and residual volume, 
were included in the study (table 1). When comparing age, 
voided volume, maximum flow rate, residual volume, esti­
m ated prostatic volume, m arital status, location of the home, 
type of house, work situation and preoperative anesthetic 
risk, significant differences (p < 0 .02) were apparent for all 
variables, indicating th a t overall patients recruited from the 
various countries were different,
This finding can be illustrated by several factors. The larg­
est group of patients from the United Kingdom were 60 to 69 
years old (45%), lived in the suburbs (88%) and were retired 
(72%), while 24% were in active work. In  Germany equal 
percentages of patients were 60 to 69 (40%) and less than  60 
(40%) years old. German patients were more likely to live in 
a city (65%) and 77% were retired, while 21% were employed. 
The largest group of patients in Italy were older than  70 
years (43%) and lived in a village (50%), and 77% of them 
were retired- Although the majority of Japanese patients 
(53%) were older th an  70 years, the proportion employed was 
considerable (40%), while only 60% were retired.
The prevalence of each symptom and the proportion of men 
reporting problems among those who had the symptom for 
the various countries as well as in the entire study group are
T a b l e  1. M e d ia n  p a t ie n t  d a ta  by coun try  separa tely  a n d  for the total sa m p le  w ith  5 th  a n d  9 5 th  percentiles
Country No. Pts. (%) Age (yra.) Prostate Vol. (cc)
Max. Flow Rate 
(ml./sec.)
Voided Vol. 
(cc) Residual Vol. (cc)
United Kingdom 214 (17) 67 30 11.3 260 100
Canada 35 (3) 61 25 10.5 158 45
Denmark 121 (9) 70 40 10.5 157 73
Germany 129 (10) 68 35 10.0 180 69
Italy 58 (4) 67 40 8.6 240 75
The N etherlands 391 (31) 65 35 12.0 228 45
Portugal 49 (4) 65 50 13.4 270 67
Sweden 73 (6) 67 30 9.9 202 50
Australia 47 (4) 65 30 17.0 200 Not given
Israel 10 (1 ) 65 40 9.7 208 90
Japan 105 (8) 70 20 10.0 170 38
Taiwan 39 (3) 69 Not given 16.0 250 50
Totals (5-9 5th  %) 1,271
ooT—“i 67 (52-80)* 35 (20-60)* 11.0 (5-24)* 213 (68-489)* 60 (9-274)*
* p < 0.01 among countries.
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T a b le  2 . Prevalence o f  sym ptom s for each country a n d  fo r  the  to ta l sa m p le
Canada Denmark Germany Italy NetI^ l a nds Portugal Sweden A ustralia Israel Jap an  Taiwan
Total No. pts. 
Terminal dribble
214
95
35
97
121
92
129
92
58
90
391
98
49
92
73
93
47
98
10
60
105
82
39
90
1,271
94
Decreased stream 92 97 97 93 91 95 83 96 87 90 93 95 93Intermittency 88 97
—Æ
90 88 74 91 73 92 89 80 79 97 88
Hesitancy 87 91 81 83 71 84 67 88 81 90 81 97 83Incomplete emptying 83 91 
^ ■  —
82 86 72 77 87 81 83 70 72 97 81
Urgency 84 79 97 76 61 73 55 71 72 80 51 82 75
Nocturia* 78 70 79 80 83 64 71 74 79 40 85 87 74
Repeated urination 78 79 76 78 57 72 48 70 66 70 48 92 71
Strain to continue 57 72 77 77 62 73 56 70 62 60 64 85 69
Post-void dribble 78 58 67 69 60 70 52 70 66 40 49 85 68
Strain to start 50 69 67 72 47 68 61 60 60 90 55 87 61
Urge incontinence 58 39 60 46 50 44 29 66 49 30 27 59 48
Frequencyt 50 64 50 37 40 48 35 49 30 50 46 43 46
Burning 39 55 41 49 45 42 52 36 42 50 17 82 42
Bladder pain 49 51 42 46 33 39 47 37 32 60 22 69 41
Incontinence, no cause 21 24 22 18 29 20 4 30 8 0 8 49 20
Sit to urinate 10 15 26 29 19 21 6 22 13 10 10 13 18
Stress incontinence 21 15 17 17 9 15 4 15 19 10 3 31 15
Urinary retention 2 0 12 24 10 7 10 11 15 10 15 26 10
Nocturnal incontinence 6 12 7 12 14 14 0 14 4 0 2 10 10
* Urination at least 2 times a night, 
f Urination at least 9 times a day.
T a b l e  3 . P roportions o f  m en  reporting  a sym p tom  to be a t least a b it  o f  a p ro b lem  a m o n g  those re p o r tin g  the s y m p to m  fo r  each  co u n try
a n d  for the to ta l sam ple
United
Kingdom Canada Denmark Germany Italy
The
Netherlands Portugal Sweden A ustralia Israel Japan Taiwan
Total 
No. Pts.
Terminal dribble 67 77 74 81 72 78 74 87 63 50 89 97 77
Decreased stream 60 81 71 80 63 75 74 71 63 67 84 92 73
Intermittency 51 74 66 67 74 68 66 65 55 62 81 92 66
Hesitancy 58 82 70 80 73 65 87 69 63 55 88 95 70
Incomplete emptying 70 86 63 82 80 70 74 80 89 71 93 95 76
Urgency 79 72 85 84 70 72 81 90 82 100 94 94 80
Nocturia* 81 91 86 86 79 83 76 91 78 75 94 94 73
Repeated urination 67 87 70 71 73 68 68 75 73 86 94 92 72
Strain to continue 60 73 67 72 80 64 88 78 79 50 86 97 71
Post-void dribble 80 94 81 85 80 84 92 80 77 50 88 97 84
Strain to start 69 75 67 77 85 47 79 64 71 57 86 97 73
Urge incontinence 79 85 90 82 83 82 86 85 77 67 100 96 84
Frequencyt 88 89 96 74 78 88 87 91 71 80 94 94 76
Burning 68 78 74 70 81 65 88 58 80 60 94 94 72
Bladder pain 60 86 67 83 84 66 78 88 53 50 96 89 72
Incontinence, no cause 72 100 88 78 88 73 100 91 75 ----------- 100 84 81
Sit to urinate 57 60 33 43 45 35 67 44 33 0 60 60 42
Stress incontinence 52 80 58 76 80 58 50 64 67 100 100 100 64
Nocturnal incontinence 83 100 88 93 62 73 — 80 100 — 100 100 81
Bold-faced numbers indicate the 
* Recoded as 0 to 1, 2 to 3 and 4 
t  Recoded as 1 to 8, 9 to 12 and
most bothersome symptoms for each country, 
or more times a night.
13 or more times a day.
shown in tables 2 and 3. In the entire study group voiding 
symptoms tended to be reported most frequently, whereas 
the most bothersome were storage symptoms.16
The results of the logistic regression analysis are shown in 
tables 4 to 7 . After controlling for possible confounding vari­
ables, the country of origin was strongly significantly associ­
ated (p < 0 .01) with the prevalence of 10 of the 20 symptoms, 
including term inal dribble, intermittency, hesitancy, u r­
gency, repeated urination, post-void dribble, urge inconti­
nence, burning, bladder pain and sitting to urinate (table 4). 
In addition, 5 symptoms were marginally significant (0.01 < 
p <0.05), including nocturia, strain  to continue, strain to 
start, incontinence of no apparent cause and urinary reten­
tion. Only stress incontinence was significant before but not 
after controlling for confounding factors. On the other hand, 
hesitancy became more significant after adjustment.
Table 5 presents odds ratios (95% confidence intervals) for 
the symptoms listed as significant in table 4. All countries 
were compared to the United Kingdom. Results for Canada, 
Portugal, A ustralia and Israel should be interpreted with 
caution given the relatively small numbers. The patterns 
evident are different for each country but there were some 
similarities. For example in the Netherlands, Denmark and
T a b le  4, S ta t is t ic a l  s ig fiificance fr o m  log istic  regression  m odels  o f  
the  associa tion  betw een the  p re v a le n c e  o f  each  sy m p to m  a n d  
country o f  orig in  before a n d  a fte r  a d ju s t in g  fo r  c o n fo u n d in g  fa c to rs
p Value for Country
Symptom ---------------------------------------------
U nadjusted Adjusted
Terminal dribble < 0.01 < 0.01
Decreased stream 0.42 0.51
Intermittency < 0.01 < 0.01
Hesitancy 0.02 < 0.01
Incomplete emptying 0.07 0.14
Urgency < 0.01 < 0.01
Nocturia 2 or more/night < 0.01 0.01
Repeated urination < 0.01 < 0.01
Strain to continue 0.02 0.01
Post-void dribble < 0.01 < 0.01
Strain to s ta rt 0.02 0,03
Urge incontinence < 0.01 < 0.01
Frequency 9 or more/day 0.12 0.10
Burning < 0.01 < 0.01
Bladder pain < 0.01 < 0.01
Incontinence, no cause 0.03 0.03
Sit to urinate 0.01 < 0.01
Stress incontinence 0.04 0.15
Urinary retention 0.03 0.02
Nocturnal incontinence 0.18 0.56
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Table 6. Statistical significance from logistic regression models of 
the association between the both ersomeness of each symptom and 
country of origin before and after adjusting for confounding factors
Bother
p Value for Country
Unadjusted Adjusted
Terminal dribble < 0.01 0.03
Decreased stream < 0.01 0.04
Intermittency 0.02 0.31
Hesitancy < 0.01 < 0.01
Incomplete emptying < 0.01 0.01 .
Urgency 0.04 0.14
Nocturia 2 or more/night 0.07 0.17
Repeated urination 0.23 0.17
Strain to continue 0,03 0.03
Post-void dribble 0.57 0.66
Strain to start < 0.01 < 0.01
Urge incontinence 0.93 0.33
Frequency 9 or more/day 0.84 0.82
Burning 0.31 0.25
Bladder pain 0.02 0.11
Incontinence, no cause 0,75 0.33
Sit to urinate 0.88 0.74
Stress incontinence 0.93 0.96
Nocturnal incontinence 0.93 0.88
Germany the symptoms of strain  to continue, s tra in  to start 
and sitting to urinate  were considerably more prevalent than 
in the United Kingdom, whereas hesitancy was less preva­
lent. Urgency and repeated urination were less prevalent in 
Italy, Sweden, Japan , The Netherlands and Germany than  in 
the United Kingdom, In other respects a considei^ably differ­
ent pattern  of symptoms was evident in Japan. In Japan  only 
urinary retention was more prevalent than in the United 
Kingdom, while term inal dribble, intermittency, hesitancy, 
urgency, repeated urination, post-void dribble, urge inconti­
nence, burning, bladder pain and incontinence of no known 
cause were less prevalent. Interestingly, all countries had a 
greater prevalence of urinary retention than  the United 
Kingdom. Overall there were marked variations in the symp­
tomatology across countries.
After controlling for possible confounding variables, the 
country of origin was strongly significantly associated (p < 0 .01) 
with bothersomeness for only 2 of the 19 symptoms for which 
this parameter was assessed, that is hesitancy and strain to 
start (table 6). In addition, the 4 symptoms marginally signifi­
cant (0.01<p <0.05) were terminal dribble, decreased stream, 
incomplete emptying and strain to continue. Three of these 4 
symptoms had been highly significant before controlling for 
confounding factors, while strain to continue was unaffected by 
adjustment. Of the 13 symptoms not significant after adjust­
ment the only 3 even marginally significant originally were 
intermittency, urgency and bladder pain.
Table 7 presents odds ratios (95% confidence intervals) for 
the symptoms listed as significant in table 6 , All countries 
were compared to the United Kingdom. Results for Canada, 
Portugal, Australia and Israel should be interpreted with 
caution given the relatively small numbers. Again, the pat­
te rn  for Japan  was ra th e r different from the other countries, 
with all 6 symptoms much more bothersome than  in the 
United Kingdom. In Germany term inal dribble, decreased 
stream, hesitancy and incomplete emptying were also highly 
bothersome, whereas for the other countries only Italy  and 
Sweden each had  a suggestion of markedly greater levels of 
bother than  the United Kingdom for the 2 symptoms of 
term inal dribble and strain  to continue. The only instance 
when bothersomeness was significantly less than  in the 
United Kingdom was strain  to s ta rt in The Netherlands.
DISCUSSION
Although international variations in the prevalence of spe 
cific lower urinary tract symptoms were clearly demon'
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stra ted  in this study, the  evidence th a t  re la ted  bother dif­
fered among countries w as m uch weaker. However, it m ust 
be considered th a t  in th is study  the  partic ipating  countries 
contributed dissim ilar groups of pa tien ts  w ith  respect to the 
investigated variables of age, voided volume, m axim um  flow 
rate, residual volume, estim ated  prostatic  volume, m arita l 
status, location of the home, work situation  and preoperative 
anesthetic risk  as indicated by th e  physician. Since these 
confounding factors m ay explain some of the in ternational 
variations, we examined these variations after adjusting for 
potentially confounding factors. I t  m ust be recognized th a t 
there are several other potential confounding factors for 
which data  were not available, such as financial sta tus, reli­
gion, occupation, hobbies, linguistic problems and cultural 
differences in the  perception of or willingness to report symp­
toms, as well as variations in  decision m aking by general 
practitioners, variations in  th e  availability of trea tm en ts  for 
lower urinary trac t symptoms, underlying variations in the 
prevalence of benign prostatic  en largem ent and prostatic 
obstruction, and differences in hea lth  care delivery systems.
After adjustm ent, country of origin was significantly asso­
ciated with half of the sym ptom s m easured, including stor­
age and voiding symptoms w ith  high and low prevalences. 
Controlling for a range of potential confounding variables 
had little effect on these relationships for 2 possible reasons: 
1) insufficient allowance m ight have been made for potential 
confounders or 2) there m ay be real in terna tional differences 
in symptom reporting among these men. However, these 
international differences may arise from several sources, such 
as patient selection, health  care organization and perceptions of 
symptoms. In particular, the wide differences noted in the 
prevalences of urinary retention support the suggestion th a t 
patient selection may be different in these countries.
It is notable th a t  there  were not such m arked differences 
for bothersomeness, although all symptoms for which there  
were in ternational differences were of the voiding type. For 
symptoms in which differences were evident reported levels 
of bothersomeness clearly were m uch lower in  the U nited 
Kingdom th an  elsewhere, w hereas Ja p a n  and G erm any re­
ported the greatest levels of bothersom eness. For bother­
someness controlling for the  confounding variables had some 
impact on the pa tte rn  of relationships, in  m ost cases decreas­
ing the  significance of th e  variation  across countries.
These observations w ere d ifferen t from  th e  repo rt of 
Burton et al, who assessed differences in a ttitudes to incon­
tinence in different m igran t groups in A ustralia. Some ethnic 
groups were concerned about th e  incontinence b u t did not tell 
the family or seek help, while o thers were active in seeking 
treatm ent. Some ethnic groups were asham ed to be inconti­
nent, while others accepted i t .17
It has been shown th a t  the  m ost frequently  reported symp­
toms are not necessarily th e  m ost bothersom e .16 In  the no rth ­
ern European countries, th a t  is th e  U nited  Kingdom, Den­
mark, The N etherlands and  Sweden, the  storage symptom of 
frequency appeared to be one of the  m ost bothersome symp­
toms. In Canada, Germany, sou thern  European countries 
(Italy and Portugal), A u s tra lia , Is ra e l and  A sian coun­
tries  (Jap an  and  T aiw an) in co n tin en ce  w as th e  m ost 
bothersom e symptom, w hich  suggested  th a t  cu ltu ra l dif­
ferences in  the  perception of sym ptom s m ay be im portan t. 
Generally, the  m ost freq u en tly  rep o rted  sym ptom s were 
associated w ith  the voiding p h ase  and  th e  m ost bo ther­
some sym ptom s were assoc ia ted  w ith  th e  storage phase or 
incontinence .16 This find ing  appears  to be tru e  for the 
m ajority of individual countries.
CONCLUSIONS
Our study indicates th a t  in te rna tiona l differences are rel­
evant in the reporting of specific lower u rinary  trac t symp­
toms and related bother. Inevitably, individual countries
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have different cu ltu ral backgrounds and specific health  care 
delivery systems. Therefore, the resu lts  of studies in specific 
countries m ay not be generally applicable in  other countries. 
In particu lar, it m ay be im portan t to consider different pat­
terns of reporting  of symptoms and bothersomeness when 
in terp re ting  the  resu lts  of studies using common question­
naires. Of course, symptoms are extrem ely im portant for 
m onitoring disease progression and outcome of trea tm en t in 
individual patien ts. M any studies use symptom scores th a t 
consolidate individual symptom differences into 1 overall 
m easurem ent, thus  potentially  concealing th is  variation. The 
In ternational Continence Society male questionnaire avoids 
these difficulties by considering each symptom separately. 
For studies th a t  use symptom scores i t  m ay be necessary to 
evaluate the  effectiveness, cost-effectiveness and influences 
on quality of life of trea tm en ts  for lower urinary  tract symp­
toms in each country, or to develop country specific scores. An 
alternative is to focus on bother, which appeared much less 
sensitive to in terna tional differences.
In  addition, th e  In ternational Continence Society “BPH” 
study will allow investigation of the role of bladder outlet 
obstruction in the  symptomatic evaluation of therapy, and 
dem onstrate the ability of urodynamic and clinical param e­
ters  to predict response to new treatm ents. Thus, the associ­
ation between u rinary  symptoms and bladder outlet obstruc­
tion m ay be evaluated so th a t  obstruction caused by the 
prostate gland can be differentiated from other conditions 
causing lower u rinary  tra c t symptoms.
O ther partic ipan ts who contributed to the study were Mr. 
Chappie, Sheffield, U nited Kingdom; Dr. Schick, Quebec and 
Dr. Gajewski, Halifax, Nova Scotia, Canada; Dr. J, Nordling, 
Bagsvaerd and Dr. C. Frim odt-M 0ller, Hellerup, Denmark; 
Dr. J . W. Thuroff, W upperta l, G erm any; Dr. D, Porru , 
Cagliari, Italy; Dr. J . L. H. R. Bosch, Rotterdam  and Dr. 
N. F. Dabhoiwala, A m sterdam , The N etherlands; Dr. Matos 
F e rre ira  an d  Dr. M endes Silva, Lisbon, Portugal; Dr, 
Rertzhog, Sundsvall, Sweden; Dr. R. J , M illard, Sydney, Aus­
tralia; Dr. I. N issenkorn, Kfar Saba, Israel; Dr. A. Kondo, 
Nagoya and Dr. Osawa, Okinawa, Japan; Dr. Tong Long Lin, 
Taipei, Taiwan, and Prof. G. A. Barbalias, P a tras  and Dr. P. 
Kalomiris, Sparta , Greece.
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EDITORIAL COMMENT
This well written article is a product of an important multinational 
study conducted by the International Continence Society to investi­
gate, among other things, the relationship between lower urinary 
tract symptoms and physiological evidence of bladder outlet obstruc­
tion among men seen by urologists. The main conclusion is that 
prevalences of many lower urinary tract symptoms vary significantly 
by country, even after controlling for confounding factors. Perhaps 
such differences would have been expected given the variability in 
the demographic characteristics of the men seen in these urology 
practices, as well as the variability in prostate related characteristics 
displayed in table 1. The populations are different enough that 
unmeasured confounders may well explain some of the observed 
variation in symptom prevalence. To what extent any real variation 
in symptoms among men visiting the participating urological prac­
tices might have reflected differences in how men are referred to 
these practices, or actual population differences in symptom occur­
rence or perception, cannot be addressed with this study design.
While the prevalences of 10 symptoms were statistically significantly 
different among the countries studied, how impressive were the ob­
served variations from the clinical perspective? Eliminating the 5 coun­
tries contributing fewer than 50 subjects (which yielded imprecise es­
timates of country specific symptom prevalence), and focusing on the 10 
symptoms that showed significant variation, the data in table 2 showed 
ranges of prevalence as close as 82 to 98% for terminal dribbling and as 
wide as 27 to 60% for urge incontinence. For several of these symptoms 
Japan appeared to be an outlier. For the 4 European countries contrib­
uting more than 100 patients the ranges of symptom prevalences ap­
peared relatively tight. These prevalences, of course, did not reflect 
adjustment for potential confounders but the raw and adjusted analy­
ses presented subsequently were not different.
Perhaps the most remarkable finding in this study was the lack of 
variation in symptom bother among the subjects from these urology 
practices in different countries, again given the differences in the 
populations that were enrolled. It may be that a common denomina­
tor that brought men to urologists in these different countries was 
the degree to which they were bothered by the symptoms. Such data 
complement population based studies, which can also attempt to 
determine whether symptom and bother differences exist at the 
community level.
Michael J , Barry
Medical Practices Evaluation Center 
Massachusetts General Hospital 
Boston, Massachusetts
